0001950047-23-005156.txt : 20231117 0001950047-23-005156.hdr.sgml : 20231117 20231117162700 ACCESSION NUMBER: 0001950047-23-005156 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231117 DATE AS OF CHANGE: 20231117 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BridgeBio Pharma, Inc. CENTRAL INDEX KEY: 0001743881 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38959 FILM NUMBER: 231419149 BUSINESS ADDRESS: STREET 1: 3160 PORTER DR. STREET 2: SUITE 250 CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: (650) 391-9740 MAIL ADDRESS: STREET 1: 3160 PORTER DR. STREET 2: SUITE 250 CITY: PALO ALTO STATE: CA ZIP: 94304 FORMER COMPANY: FORMER CONFORMED NAME: BridgeBio Pharma LLC DATE OF NAME CHANGE: 20180618 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Kumar Neil CENTRAL INDEX KEY: 0001742485 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O BRIDGEBIO PHARMA, INC. STREET 2: 3160 PORTER DR, STE 250 CITY: PALO ALTO STATE: CA ZIP: 94304 144 1 primary_doc.xml 144 0001742485 XXXXXXXX LIVE 0001743881 BRIDGEBIO PHARMA INC 001-38959 3160 Porter Drive Suite 250 Palo Alto CA 94304 6503919740 NEIL KUMAR Officer COMMON Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Fl. New York NY 10004

51552 1487790.72 173967052 11/17/2023 NASDAQ Common 11/16/2023 Restricted Stock Units Issuer N 51552 11/16/2023 N/A Y 11/17/2023 12/05/2022 /s/ Neil Kumar